Celgene Corporation (NASDAQ:CELG) – U.S. FDA approves Celgene drug for psoriatic arthritis

[Reuters] – U.S. health regulators on Friday approved a Celgene Corp drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. . . . → Read More: Celgene Corporation (NASDAQ:CELG) – U.S. FDA approves Celgene drug for psoriatic arthritis Similar Articles: Bristol-Myers Squibb Company (NYSE:BMY) | FDA approves Bristol-Myers drug for rare body fat disorder Stock Update: Johnson & Johnson (NYSE:JNJ) – J&J, Pharmacyclics drug gets U.S. approval for leukemia Merck & Co. Inc. (NYSE:MRK) – FDA panel says Merck’s allergy drug effective